Sweeping Changes At CDER Recommended In IoM Drug Safety Report
This article was originally published in The Tan Sheet
Executive Summary
FDA's Center for Drug Evaluation & Research is "an organization in urgent need of great change," the Institute of Medicine's Assessment of the U.S. Drug Safety System Committee concludes in a Sept. 22 final report
You may also be interested in...
FDA Commissioner Search Should Adopt Team Approach – Stakeholders
The Obama administration's search for FDA's next leader should center on finding a team of qualified people - rather than just a single commissioner - to head the agency, former FDA officials and industry executives say
FDA Commissioner Search Should Adopt Team Approach – Stakeholders
The Obama administration's search for FDA's next leader should center on finding a team of qualified people - rather than just a single commissioner - to head the agency, former FDA officials and industry executives say
FDA Commissioner Search Should Adopt Team Approach – Stakeholders
The Obama administration's search for FDA's next leader should center on finding a team of qualified people - rather than just a single commissioner - to head the agency, former FDA officials and industry executives say